SIM
TVRD

Sonora Investment Management’s Tvardi Therapeutics TVRD Stock Holding History

Sonora Investment Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11
Closed -$6K – 1761
2019
Q4 		$6K Hold
11
– – ﹤0.01% 1361
2019
Q3 		$7K Hold
11
– – ﹤0.01% 1324
2019
Q2 		$9K Hold
11
– – ﹤0.01% 1242
2019
Q1 		$8K Hold
11
– – ﹤0.01% 1132
2018
Q4 		$5K Hold
11
– – ﹤0.01% 1032
2018
Q3 		$10K Hold
11
– – ﹤0.01% 881
2018
Q2 		$8K Hold
11
– – ﹤0.01% 886
2018
Q1 		$4.95K Hold
11
– – ﹤0.01% 951
2017
Q4 		$4.9K Hold
11
– – ﹤0.01% 963
2017
Q3 		$5.48K Sell
11
-11
-50% -$5.51K ﹤0.01% 844
2017
Q2 		$12.3K Hold
22
– – ﹤0.01% 638
2017
Q1 		$14.7K Hold
22
– – ﹤0.01% 586
2016
Q4 		$7.43K Hold
22
– – ﹤0.01% 657
2016
Q3 		$6.68K Buy
+22
New +$4.77K ﹤0.01% 645

Other funds holding TVRD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sonora Investment Management's TVRD Position: Q1 2020 in Review

Sonora Investment Management sold out of Tvardi Therapeutics (TVRD) in Q1 2020, closing a stake of 11 shares — an estimated $6K sold.

Sonora Investment Management first reported a position in TVRD in Q3 2016 and held it in 14 quarters. The position peaked at $14.7K in Q1 2017. 133 funds tracked by Wall St. Rank hold TVRD as of Q1 2020.

  • Sonora Investment Management reported no remaining Tvardi Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Sonora Investment Management sold 11 Tvardi Therapeutics shares in Q1 2020, an estimated $6K.
  • Sonora Investment Management first reported a position in Tvardi Therapeutics in Q3 2016 and held it in 14 quarters.
  • Sonora Investment Management's Tvardi Therapeutics position peaked at $14.7K in Q1 2017.
  • 133 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2020.

Based on Sonora Investment Management's 13F filing for Q1 2020, filed 29 Apr 2020.